Due Diligence

Rob Carter

“Transactional diligence for physician services, post-acute care, and life sciences requires informed, data-driven evaluations from every angle.”

Rob Carter
Senior Vice President

Mitigate Risk and Quantify Opportunity

Led by former Wall Street and private equity executives and complemented by expert healthcare policy, reimbursement, and commercialization advisors, our research group goes beyond the surface using public and proprietary data products to support private equity and sell-side investment decisions. Thinking like investors, we deliver customized, deep, data-driven analysis to quantify relevant risks, opportunities, and trends to inform financial models and potential goal achievement.

Customized Solutions

Whether you represent a PE firm, investment bank, or strategic investor, we can help you manage and measure the headwind and tailwind risks facing the contemplated investment.
Enrollment Projections
Payer and Provider Interviews and Surveys
Medicare and Commercial Data Analysis
Medicare and Commercial Reimbursement Assessments
Portfolio Company and Competitive Analyses
Quantified Policy Impacts
Regulatory Analysis
Utilization Trends